We recently achieved a milestone in building out data commons technology for the Blood Profiling Atlas in Cancer (BloodPAC) by adding the first set of users. BloodPAC is a consortium effort working to accelerate the development and validation of liquid biopsy assays to improve the outcomes of patients with cancer. We are contributing our data commons technology to build out a collaborative infrastructure that enables sharing of information between stakeholders in industry, academia, and regulatory agencies.